BBIO

Q: What is the price of BridgeBio Pharma (BBIO) today?

The current price of BridgeBio Pharma (BBIO) is $ 68.22, representing a 102.37% gain over the past year. The stock began the year trading around $ 76.49 and is currently priced at $ 68.22. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does BridgeBio Pharma (BBIO) pay dividends?

BridgeBio Pharma (BBIO) did not pay dividends over the past year.

BridgeBio Pharma Inc.

Price

$ 68.22

return (12m)

102.37%

p/e

-17.65

p/bv

-5.61

DIVIDEND YIELD

0.00%

BBIO price

BBIO

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment BBIO

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-11.03%

3 months

-3.54%

1 year

102.37%

2 years

131.10%

5 years

17.82%

10 years

0.00%

Fundamentals BBIO

review the fundamentals of BridgeBio Pharma shares

P/E

-17.65

Sector: -3.71 Industry: -3.71

P/S (PSR)

21.96

Sector: -4.14 Industry: -4.14

P/BV

-5.61

Sector: 1.95 Industry: 1.95

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-52.63%

Sector: -63.73% Industry: -63.73%

ROE

31.80%

Sector: -64.07% Industry: -64.07%

ROIC

-85.78%

Sector: -2,605.25% Industry: -2,605.25%

NET MARGIN

-100.00%

Sector: -39.40% Industry: -39.40%

GROSS MARGIN

95.13%

Sector: 37.14% Industry: 37.14%

OPERATING MARGIN

-86.94%

Sector: -38.64% Industry: -38.64%

EV/EBITDA

-23.80

Sector: -3.81 Industry: -3.81

EV/EBIT

-23.56

Sector: -3.88 Industry: -3.88

PRICE-TO-ASSETS

9.29

Sector: 1.42 Industry: 1.42

BVPS

-11.64

Sector: 1.96 Industry: 1.96

EPS

-3.70

Sector: -2.09 Industry: -2.09

EQUITY-TO-ASSETS RATIO

-1.65

Sector: 0.43 Industry: 0.43

LIABILITIES / ASSETS

2.65

Sector: 0.40 Industry: 0.40

CAGR REVENUE 5 YEARS

52.76%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

5.10%

Sector: - Industry: -

Fundamentals BBIO

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	26.06	6.75	25.92%	2.28%	$ 548.24 B	21.83%
PFE	18.93	1.57	8.29%	6.90%	$ 141.82 B	11.83%
ABBV	101.97	-56.06	-54.98%	3.22%	$ 370.66 B	5.79%
NVO	10.37	6.26	60.40%	4.21%	$ 196.74 B	37.15%
MRK	31.14	6.06	19.45%	2.95%	$ 278.25 B	13.59%
AZN	27.42	6.01	21.93%	1.74%	$ 284.89 B	17.19%
GILD	17.36	6.83	39.33%	2.48%	$ 160.03 B	30.99%
BMY	16.05	5.81	36.19%	4.36%	$ 116.80 B	15.01%
ZTS	12.41	10.14	81.75%	2.61%	$ 32.80 B	27.79%
REGN	14.80	2.08	14.08%	0.57%	$ 65.49 B	29.65%
HALO	22.81	36.23	158.82%	0.00%	$ 7.96 B	23.13%
AMGN	22.29	18.92	84.87%	3.00%	$ 173.86 B	20.96%
MCK	19.86	-113.39	-570.98%	0.41%	$ 94.57 B	1.18%
HRMY	11.88	1.90	16.00%	0.00%	$ 1.73 B	16.20%
VRTX	25.56	5.73	22.41%	0.00%	$ 110.89 B	35.51%
CAH	30.11	-17.52	-58.20%	1.03%	$ 46.82 B	0.62%
ADMA	11.96	5.07	42.37%	0.00%	$ 1.98 B	32.43%
BIIB	20.56	1.51	7.36%	0.00%	$ 28.21 B	13.81%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*The value considers the reinvestment of dividends.

BBIO Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT BridgeBio Pharma

BridgeBio Pharma Inc.

Average Investor10 user rating

4.0 (3 people)

United States

7 years

Founded: 2019

2019

Time since IPO - 7 years

396

Employees

BridgeBio Pharma Inc. (United States) is listed on the Nasdaq and has a market capitalization of $12.74 Billions, with shareholders equity totaling $-2.27 Billions.

The company employs approximately 396 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, BridgeBio Pharma Inc. reported $579.95 Millions in revenue, generating net income of $-721.54 Millions.

Key financial metrics include a P/E ratio of -17.65, a price-to-book (P/B) ratio of -5.61, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker BBIO.

Market cap

$ 12.74 Billions

Net worth

$ -2.27 Billions

$ -2,268,880,000.00

Assets

$ 1.37 Billion

$ 1,370,980,000.00

Total Shares Outstanding

195.00 Millions

195,000,000

Average Daily Trading Volume

$ 2.35 Millions

$ 2,347,441.40

Sector

Health Care

Industry

Biotechnology

BBIO

BBIO revenue and profits

Financial Results BBIO

DRAG THE FRAME TO SEE MORE DATA

BBIO cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 754.68 6,73% (12M)

P/E

19.86

0.41%

ROE

-570.98%

P/BV

-113.39

CAH - Cardinal Health

$ 199.23 32,48% (12M)

P/E

30.11

1.03%

ROE

-58.20%

P/BV

-17.52

JNJ - Johnson & Johnson

$ 229.32 55,38% (12M)

P/E

26.06

2.28%

ROE

25.92%

P/BV

6.75

MRK - Merck & Co.

$ 113.00 50,41% (12M)

P/E

31.14

2.95%

ROE

19.45%

P/BV

6.06

AZN - AstraZeneca

$ 187.46 36,35% (12M)

P/E

27.42

1.74%

ROE

21.93%

P/BV

6.01

ABBV - AbbVie

$ 212.30 20,00% (12M)

P/E

101.97

3.22%

ROE

-54.98%

P/BV

-56.06

NVO - Novo Nordisk

$ 45.07 --30,69% (12M)

P/E

10.37

4.21%

ROE

60.40%

P/BV

6.26

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 754.68 6,73% (12 M)

P/L

19.86

0.41%

ROE

-570.98%

P/VP

-113.39

CAH - Cardinal Health

$ 199.23 32,48% (12 M)

P/L

30.11

1.03%

ROE

-58.20%

P/VP

-17.52

JNJ - Johnson & Johnson

$ 229.32 55,38% (12 M)

P/L

26.06

2.28%

ROE

25.92%

P/VP

6.75

MRK - Merck & Co.

$ 113.00 50,41% (12 M)

P/L

31.14

2.95%

ROE

19.45%

P/VP

6.06

AZN - AstraZeneca

$ 187.46 36,35% (12 M)

P/L

27.42

1.74%

ROE

21.93%

P/VP

6.01

ABBV - AbbVie

$ 212.30 20,00% (12 M)

P/L

101.97

3.22%

ROE

-54.98%

P/VP

-56.06

NVO - Novo Nordisk

$ 45.07 --30,69% (12 M)

P/L

10.37

4.21%

ROE

60.40%

P/VP

6.26

Frequently Asked Questions

What is the price of BridgeBio Pharma (BBIO) today?

The current price of BridgeBio Pharma (BBIO) is $ 68.22, representing a 102.37% gain over the past year. The stock began the year trading around $ 76.49 and is currently priced at $ 68.22. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does BridgeBio Pharma (BBIO) pay dividends?

BridgeBio Pharma (BBIO) did not pay dividends over the past year.

Is BridgeBio Pharma (BBIO) a good investment?

BridgeBio Pharma (BBIO) is currently trading at $ 68.22 with a P/E ratio of -17.65. This represents a -1,215% premium compared to its historical average P/E. Over the past year, the stock has gained 102.37 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 102.37%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy BridgeBio Pharma (BBIO) stock?

You can buy BridgeBio Pharma (BBIO) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol BBIO and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of BridgeBio Pharma (BBIO) yield today?

Over the past month, BridgeBio Pharma (BBIO) has returned -11.03% — 102.37% over the past year, and 17.82% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of BridgeBio Pharma (BBIO) today at the current price of $ 68.22 your total investment would be $ 6,822.00.

Based on historical performance, the investment would have grown to approximately:

$ 13,805.68 after 1 year
$ 8,037.68 after 5 years
$ 6,822.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

BBIO

BridgeBio Pharma Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment BBIO

review the fundamentals of BridgeBio Pharma shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

current DY: 0.00%

5-year average DY: 0.00%

ABOUT BridgeBio Pharma

BridgeBio Pharma Inc.

United States

7 years

2019

396

PROFIT X PRICE BBIO

Financial Results BBIO

BBIO cash flow

Asset, Revenue and Profit Growth - BBIO

BBIO balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

Frequently Asked Questions